Calvo et al. discuss how applying genetic techniques, from model organisms to human populations, can help us understand the pathophysiology of neuropathic pain. These strategies could soon reveal novel analgesic drug targets and aid both personalized risk prediction and treatment.
from journals https://ift.tt/35jacd2
from journals https://ift.tt/35jacd2
Comments
Post a Comment